9-Gene Classifier Improves Metastasis Prediction in STS, Cancers
- Here's a breakdown of the key data from the provided text, focusing on the new prognostic model for Soft Tissue Sarcomas (STS):
- * The Problem: Currently, ther's no widely available gene expression profile test for clinical diagnosis of STS, despite ongoing research to identify common genetic characteristics for prognosis.
Here’s a breakdown of the key data from the provided text, focusing on the new prognostic model for Soft Tissue Sarcomas (STS):
* The Problem: Currently, ther’s no widely available gene expression profile test for clinical diagnosis of STS, despite ongoing research to identify common genetic characteristics for prognosis.
* The New Model: Researchers developed a machine learning-driven model based on analyzing thousands of tumor samples.
* Key Genes: The model ultimately relies on a set of 9 genes: TNXB, ABCA8, ACTN1, EIF4EBP1, PVR, CLIC4, STAU2, ATAD2, and TBC1D31.
* How it Works: The model classifies patients into low-risk and high-risk groups.
* Validation: The model consistently performed well across multiple STS datasets, showing statistically significant separation of risk groups.
* Comparison to Existing Methods: The model’s accuracy was benchmarked against 5 widely used prognostic signatures.
* CINSARC: The text also mentions the Complexity Index in Sarcomas (CINSARC), a transcriptomic signature based on 67 genes that divides patients into 2 risk groups.
* Potential Impact: The researchers believe such models are crucial for providing patients and healthcare workers with information to guide treatment decisions.